{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:21:39Z","timestamp":1787530899486,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd004385.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T00:00:00Z","timestamp":1273622400000}}],"reference-count":114,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004385.pub3","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T16:33:02Z","timestamp":1273595582000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Methotrexate for primary biliary cirrhosis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Vanja","family":"Giljaca","sequence":"first","affiliation":[{"name":"Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Poropat","sequence":"additional","affiliation":[{"name":"Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davor","family":"Stimac","sequence":"additional","affiliation":[{"name":"Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,12]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"632; author rep","DOI":"10.1002\/hep.21058","article-title":"Methotrexate for treatment of primary biliary cirrhosis","volume":"43","author":"Bonis","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0004|cit2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.20936","article-title":"Reflections on therapeutic trials in primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD004385.pub3-BIB0003|cit3","first-page":"211A","article-title":"The primary biliary cirrhosis (PBC) ursodiol (UDCA) plus methotrexate (MTX) or its placebo study (PUMPS) - a multicenter randomised trial (AASLD abstract)","volume":"38","author":"Combes","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0002|cit4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"633; author rep","DOI":"10.1002\/hep.21104","article-title":"Reflections on therapeutic trials in primary biliary cirrhosis: A quality of life oriented counter-view (correspondence)","volume":"43","author":"Jones","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004385.pub3-BIB0006|cit6","first-page":"392A","article-title":"Absence of pulmonary toxicity in primary biliary cirrhosis (PBC) treated with methotrexate and ursodiol (AASLD abstract)","volume":"28","author":"Munoz","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0007|cit7","first-page":"N\/A","article-title":"Methotrexate in combination with ursodeoxycholic acid is ineffective in the treatment of primary biliary cirrhosis (Comment)","volume":"N\/A","author":"Zaman","year":"2006","journal-title":"Evidence-Based Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-8278(01)80199-9","article-title":"Ursodeoxycholic acid and methotrexate for primary biliary cirrhosis (abstract)","volume":"34","author":"Copaci","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(97)80294-2","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone","volume":"27","author":"Gonzalez-Koch","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004385.pub3-BIB0010|cit10","first-page":"A30","article-title":"Low-dose methotrexate in treatment of primary biliary cirrhosis (abstract)","volume":"36","author":"Giaffer","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub3-BIB0012|cit12","first-page":"176A","article-title":"Double-blind trial of methotrexate (MTX) versus colchicine (COLCH) in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"18","author":"Kaplan","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"issue":"9097","key":"10.1002\/14651858.CD004385.pub3-BIB0016|cit14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(05)78176-9","article-title":"Primary biliary cirrhosis (letter)","volume":"17","author":"Kaplan","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub3-BIB0014|cit15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.20103","article-title":"A randomised controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results","volume":"39","author":"Kaplan","year":"2004","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub3-BIB0015|cit16","first-page":"152A","article-title":"Methotrexate (MTX) improves histology in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"20","author":"Kaplan","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0017|cit17","first-page":"518","article-title":"Synthesis of Interleukin-1beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression","volume":"22","author":"Miller","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0016-5085(94)90085-X","article-title":"Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis","volume":"107","author":"Sharma","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j1365-2036.2006.03048x","article-title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","volume":"24","author":"Babatin","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0020|cit20","first-page":"342","article-title":"The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis","volume":"122","author":"Bach","year":"1998","journal-title":"Archives of Pathology and Laboratory Medicine"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub3-BIB0021|cit21","first-page":"124A","article-title":"Two year histologic follow-up of the effects of methotrexate on primary biliary cirrhosis (AASLD abstract)","volume":"122","author":"Bach","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1572-0241.2003.07173.x","article-title":"Methotrexate therapy for primary biliary cirrhosis","volume":"98","author":"Bach","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0023|cit23","first-page":"295","article-title":"Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis","volume":"91","author":"Bergasa","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(05)80004-2","article-title":"Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone","volume":"18","author":"Buscher","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD004385.pub3-BIB0026|cit26","first-page":"A720","article-title":"Oral methotrexate (MTX) for primary biliary cirrhosis (PBC): preliminary report (AASLD abstract)","volume":"100","author":"Bergasa","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0016-5085(91)90100-Y","article-title":"Methotrexate therapy of primary biliary cirrhosis: promising but worrisome","volume":"101","author":"Hoofnagle","year":"1991","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(92)91761-R","article-title":"Methotrexate for primary biliary cirrhosis (letter)","volume":"102","author":"Kaplan","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","article-title":"Primary biliary cirrhosis treated with low-dose oral pulse methotrexate","volume":"109","author":"Kaplan","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD004385.pub3-BIB0030|cit30","first-page":"92A","article-title":"The therapeutic effects of ursodiol and methotrexate are additive and well tolerated in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"16","author":"Kaplan","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0035|cit31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/hep.1840120427","article-title":"Methotrexate hepatotoxicity and the premature reporting or Mark Twain's death: both greatly exaggerated","volume":"12","author":"Kaplan","year":"1990","journal-title":"Hepatology"},{"issue":"268","key":"10.1002\/14651858.CD004385.pub3-BIB0036|cit32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/oxfordjournals.qjmed.a068368","article-title":"Methotrexate treatment of chronic cholestatic liver disease: friend or foe?","volume":"72","author":"Kaplan","year":"1989","journal-title":"Quarterly Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0037|cit33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007191","article-title":"The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis","volume":"17","author":"Kaplan","year":"1997","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0031|cit34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub3-BIB0033|cit35","first-page":"585","article-title":"Effective treatment of pre-cirrhotic primary biliary cirrhosis (PBC) with methotrexate (MTX): remission in some (AASLD abstract)","volume":"10","author":"Kaplan","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0034|cit36","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0032|cit37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","article-title":"Primary biliary cirrhosis treated with low-dose oral pulse methotrexate","volume":"109","author":"Kaplan","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004385.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD004385.pub3-BIB0039|cit39","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub3-BIB0040|cit40","first-page":"157","article-title":"The combination of ursodeoxycholic acid (UDCA) and methotrexate (MTX) for patients with primary biliary cirrhosis (PBC): the results of a pilot study (AASLD abstract)","volume":"20","author":"Lindor","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0041|cit41","first-page":"S41","article-title":"One year treatment with methotrexate (MTX) in patients with primary biliary cirrhosis (PBC) (abstract)","volume":"16","author":"Steenbergen","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0042|cit42","first-page":"246","article-title":"Methrotrexate alone or in combination with ursodeoxycholic acid as possible treatment in primary biliary cirrhosis","volume-title":"Cholestatic Liver diseases: New Strategies for Prevention and Treatment of Hepatobiliary and Cholestatic Liver Diseases. Falk Symposium 75","author":"Steenbergen","year":"1994"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0043|cit43","unstructured":"Van Steenbergen W Methotrexate in primary biliary cirrhosis and sclerosing cholangitis Klinische Hepatologie 1995 6 10"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/17843286.1996.11718480","article-title":"Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis","volume":"51","author":"Steenbergen","year":"1996","journal-title":"Acta Clinica Belgica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004385.pub3-BIB0045|cit45","first-page":"187","article-title":"Combined treatment with methotrexate and ursodeoxycholic acid in primary biliary cirrhosis (PBC) (EASL abstract)","volume":"21","author":"Steenbergen","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub3-BIB0046|cit46","first-page":"A1406","article-title":"Methotrexate therapy in primary biliary cirrhosis is of limited efficacy and accompanied by serious side effects (AASLD abstract)","volume":"112","author":"Vandeputte","year":"1997","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003459.pub2","article-title":"Methotrexate for induction of remission in refractory Crohn's disease","author":"Alfadhli","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0048|cit48","first-page":"219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"issue":"8410","key":"10.1002\/14651858.CD004385.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(84)91108-5","article-title":"Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis","volume":"3","author":"Ballardini","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis: a progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0054|cit54","article-title":"Antimetabolites","volume-title":"Cancer Chemotherapy: Principles and Practice","author":"Chu","year":"1995"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000391","article-title":"Methotrexate as a steroid sparing agent for asthma in adults","author":"Davies","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"16","key":"10.1002\/14651858.CD004385.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD004385.pub3-BIB0058|cit58","first-page":"629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"8233","key":"10.1002\/14651858.CD004385.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004385.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0016-5085(82)80125-X","article-title":"The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"83","author":"Epstein","year":"1982","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0062|cit62","first-page":"A1121","article-title":"Antimitochondrial antibodies AMA of primary biliary cirrhosis PBC recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha ketoacid dehydrogenase complex","volume":"3","author":"Fregeau","year":"1989","journal-title":"Faseb Journal"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0063|cit63","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2010, Issue 3. Art. No.: LIVER"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004481.pub2","article-title":"Colchicine for primary biliary cirrhosis","author":"Gong","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000551.pub2","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gong","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD004385.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Colloboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD004385.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0071|cit71","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","article-title":"Evolution of treatment effects over time: empirical insight from recursive cumulative meta analyses","volume":"98","author":"Ioannidis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8233","key":"10.1002\/14651858.CD004385.pub3-BIB0074|cit74","first-page":"1278","article-title":"Primary biliary cirrhosis - a revised clinical spectrum","volume":"1","author":"James","year":"1981","journal-title":"Lancet"},{"issue":"19","key":"10.1002\/14651858.CD004385.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199405123301912","article-title":"Primary biliary cirrhosis - a first step in prolonging survival","volume":"330","author":"Kaplan","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD004385.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a U.S. community","volume":"119","author":"Kim","year":"2000","journal-title":"Gatroenterology"},{"issue":"11","key":"10.1002\/14651858.CD004385.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0080|cit80","first-page":"247","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"90","author":"Lacerda","year":"1995","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0083|cit83","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD004385.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"issue":"9039","key":"10.1002\/14651858.CD004385.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0088|cit88","first-page":"S86","article-title":"Methotrexate inhibits interleukin-1 activity","volume":"29","author":"Miller","year":"1986","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"9128","key":"10.1002\/14651858.CD004385.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","article-title":"Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease","volume":"24","author":"Nyberg","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomised trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub3-BIB0095|cit95","first-page":"171A","article-title":"Symptom development and prognosis of initially asymptomatic PBC","volume":"32","author":"Prince","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gatroenterology"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clinics in Liver Disease"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0098|cit98","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"12","key":"10.1002\/14651858.CD004385.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cld.2008.02.008","article-title":"Treatment of primary biliary cirrhosis: Therapy with choleretic and immunosuppressive agents","volume":"12","author":"Silveira","journal-title":"Clinics in Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub3-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000957","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub3-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003129","article-title":"Methotrexate for treating juvenile idiopathic arthritis","author":"Takken","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004385.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1365-2036.1996.70244000.x","article-title":"Review article: methotrexate in gastroenterology - dangerous villain or simply misunderstood?","volume":"10","author":"Tang","year":"1996","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0106|cit106","first-page":"124","article-title":"A study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0168-8278(86)80483-4","article-title":"Expression of MHC products by normal and abnormal bile duct epithelium","volume":"3","author":"Oord","year":"1986","journal-title":"Jounal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD004385.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Journal of Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD004385.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"7644","key":"10.1002\/14651858.CD004385.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.1840060309","article-title":"Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis","volume":"6","author":"Yamada","year":"1986","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub3-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004385.pub2","article-title":"Methotrexate for primary biliary cirrhosis","author":"Gong","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004385.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:05:03Z","timestamp":1787529903000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004385.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,5,12]]},"references-count":114,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004385.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,12]]}}}